| dc.contributor.author | Pérez Arana, Gonzalo Martín | |
| dc.contributor.author | Prada Oliveira, José Arturo | |
| dc.contributor.other | Anatomía y Embriología Humana | es_ES |
| dc.date.accessioned | 2021-02-10T13:13:24Z | |
| dc.date.available | 2021-02-10T13:13:24Z | |
| dc.date.issued | 2021-01 | |
| dc.identifier.uri | http://hdl.handle.net/10498/24468 | |
| dc.description | Data file | es_ES |
| dc.description.abstract | Roux en Y Gastric bypass is the gold standard surgical method in bariatric surgery, with a severe improvements in the Type 2 Diabetic mellitus. But, many patients used to relapse to the diabetic status five years after this aggressive surgical procedure. We focused on the changes in the beta-cell population and absorptive intestinal consequences after RYGB in a healthy non-obese animal model after a long survival period. To our purpose, we used three Wistar rat groups: RYGB-operated, surgical control (Sham) and fasting control. We measured: alfa-cell and beta-cell mass; transcription -Arx, Pdx-1 and Pax6- and proliferation –Pdx-1- factors; glucose tolerance and insulin release after oral glucose tests; histological adaptive changes in jejunum and intestinal glucose transporter. | es_ES |
| dc.format | application/pdf | es_ES |
| dc.language.iso | eng | es_ES |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | beta-cells | es_ES |
| dc.subject | pancreas | es_ES |
| dc.subject | glucagon | es_ES |
| dc.subject | Roux-Y gastric bypass | es_ES |
| dc.subject | incretines | es_ES |
| dc.subject | cellular differentiation | es_ES |
| dc.title | The long-term failure of RYGB surgery in T2DM improvement is related to hyperinsulinism. | es_ES |
| dc.type | other | es_ES |
| dc.rights.accessRights | open access | es_ES |